On February 7, 2025 Nusano, a physics company transforming the production of radioisotopes, reported the company’s CFO Pushkar Bedekar will present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 (Press release, Nusano, FEB 7, 2025, View Source [SID1234650098]). The presentation will highlight Nusano’s 2025 commercialization plans and provide an overview of how the company will leverage its proprietary technologies to make new supplies of rare and hard-to-produce radioisotopes available for medical and commercial markets.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
WHO:
Nusano CFO Pushkar Bedekar
WHAT:
Company Presentation
WHEN:
Tuesday, Feb. 11, 2025
1:20 – 1:50 PM Eastern
WHERE:
Virtual Event – Oppenheimer 35th Annual Healthcare Life Sciences Conference
To listen to the webcast, please contact your representative at Oppenheimer and request a link.